Up to £20 million is available for multidisciplinary consortia to develop and evaluate integrated diagnostic solutions for early detection and diagnosis. This includes funding from the Industrial Strategy Challenge Fund (ISCF).
Programme: Innovate UK
Award: Share of up to £20 million
Opens: 22nd Jul 2019
Closes: 23rd Sep 2019
This competition aims to accelerate development of innovative diagnostic tools and technologies by multi-disciplinary and cross-sector consortia.
Your application must aim to integrate across technologies, data, care pathways and systems to deliver new diagnostic systems for the early detection and diagnosis of diseases. Your consortium must work with the UK’s health and care infrastructure to advance the development of integrated diagnostic solutions.
It is encouraged that you be ambitious in your integration of multiple detection or diagnostic technologies and approaches, potentially arising from multiple commercial or academic settings.
Innovate UK want to build on investments that have been made to date. This can include those made:
You can choose to create new products, processes and services that integrate across technologies, data, care pathways and systems to deliver new diagnostic solutions for early detection and diagnosis of diseases. You must consider how your solution will fit into existing or feasible care pathways and generate evidence that will support the adoption of your proposed new products, processes and/or services.
You can use the following approaches:
1.Integrating technological approaches to improve early detection and diagnostic accuracy, including:
2.Integrating new diagnostic solutions into care pathways
3.Evaluating new integrated diagnostic solutions (such as performance characteristics, clinical impact, health economic evaluations and the collection of real-world evidence) as part of the wider programme of work, to provide information that will aid adoption
Disease areas in scope include but are not limited to:
Your project can build on the capabilities of existing infrastructure but we are not looking to fund the development of new infrastructure.
Early detection and diagnosis must be the focus of your proposal. You can also include work packages on monitoring, treatment selection and patient management.
Innovate UK are especially looking for projects that focus on one or more of the following:
To lead a project your organisation must be:
Each organisation can lead on up to 2 applications. You must collaborate with other organisations as outlined in the Project team section. We encourage you to include more than one business.
To collaborate with the lead organisation your organisation must:
Your consortium must have at least 3 partners (including the lead) and involve:
The lead and at least one other organisation must claim funding and enter their costs as part of the application.
There is no limit to the number of applications that an eligible organisation can collaborate on.
There is up to £17 million allocated to fund innovation projects in this competition. Up to £3 million is also being invested by Cancer Research UK for oncology-focused projects only.
Your project’s total eligible costs, including industry contributions and any other co-funding, must not exceed £10 million. Your consortium can apply for a maximum grant of £3.5 million.
Projects must start by 1 January 2020 and can last for up to 36 months.
For industrial research projects, you could receive funding for your eligible project costs of:
For experimental development projects and work packages within these, which are nearer to market, you could get funding for your eligible project costs of:
The research organisations collaborating as part of a consortium may share up to 50% of the eligible project costs. If your consortium contains more than one research organisation, this maximum will be shared between them.
Innovate UK are not funding: